Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. et al
Veloxis Pharmaceuticals, Inc. |
Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd. |
1:2022cv00909 |
July 7, 2022 |
US District Court for the District of Delaware |
Maryellen Noreika |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on August 8, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Krista M. Rycroft - filed by Veloxis Pharmaceuticals, Inc.. (Tigan, Jeremy) |
SO ORDERED re #10 MOTION for Pro Hac Vice Appearance of Attorney Krista M. Rycroft filed by Veloxis Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 8/8/2022. (dlw) |
Filing 9 WAIVER OF SERVICE returned executed by Veloxis Pharmaceuticals, Inc.: For Intas Pharmaceuticals Ltd. waiver sent on 7/11/2022, answer due 9/9/2022. (Tigan, Jeremy) |
Filing 8 WAIVER OF SERVICE returned executed by Veloxis Pharmaceuticals, Inc.: For Accord Healthcare, Inc. waiver sent on 7/11/2022, answer due 9/9/2022. (Tigan, Jeremy) |
Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, James E. Baker and Anastasia M. Fernands - filed by Veloxis Pharmaceuticals, Inc.. (Blumenfeld, Jack) |
SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Berdon, James E. Baker and Anastasia M. Fernands filed by Veloxis Pharmaceuticals, Inc. Ordered by Judge Maryellen Noreika on 7/15/2022. (asw) |
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
Filing 6 Summons Issued as to Accord Healthcare, Inc. on 7/7/2022; Intas Pharmaceuticals Ltd. on 7/7/2022. (Attachments: #1 Summons Issued)(srs) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Asahi Kasei Corp. for Veloxis Pharmaceuticals, Inc. filed by Veloxis Pharmaceuticals, Inc. (srs) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,685,998 B2 ; 9,549,918 B2; 10,166,190 B2; 10,864,199 B2; 11,110,081 B2; 11,123,331 B2. (srs) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/26/2022. Date of Expiration of Patent: See Attached Form.Thirty Month Stay Deadline: 11/26/2024. (srs) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
Filing 1 COMPLAINT filed against Accord Healthcare, Inc., Intas Pharmaceuticals Ltd. ( Filing fee $ 402, receipt number ADEDC-3911285.) - filed by Veloxis Pharmaceuticals, Inc. (Attachments: #1 Exhibit A-G, #2 Civil Cover Sheet)(srs) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.